Free Trial

Addex Therapeutics (ADXN) SEC Filings & 10K Form

Addex Therapeutics logo
$8.58 +0.79 (+10.14%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Addex Therapeutics SEC Filings

DateFilerForm TypeView
04/30/2025
5:05 AM
Addex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2025
5:18 AM
Addex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2025
5:05 AM
Addex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/22/2024
5:00 AM
Addex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
5:01 AM
Addex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2024
5:05 AM
Addex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
5:05 AM
Addex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
7:12 PM
Addex Therapeutics (Subject)
Growth Equity Opportunities Fund IV, LLC (Filed by)
Form SC 13D/A
08/05/2024
8:00 PM
Addex Therapeutics (Subject)
Growth Equity Opportunities Fund IV, LLC (Filed by)
Form SC 13D/A
07/22/2024
5:05 AM
Addex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
5:05 AM
Addex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
5:05 AM
Addex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2024
5:00 AM
Addex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/05/2024
5:05 AM
Addex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ADXN) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners